SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Axsome Therapeutics Q1 EPS $(0.880) Misses $(0.620) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.880) per share which missed the analyst consensus estimate of $(0.620) by 41.94 percent. This is a 175 percent decrease over losses of $(0.320) per share

Benzinga · 05/08/2020 11:17

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.880) per share which missed the analyst consensus estimate of $(0.620) by 41.94 percent. This is a 175 percent decrease over losses of $(0.320) per share from the same period last year.